Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336583
Status:
COMPLETED
Last Update Posted:
2018-06-26
First Post:
2006-06-13
Brief Title:
Etoposide Methylprednisolone High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkins Lymphoma NHL
Sponsor:
Asan Medical Center
Organization:
Asan Medical Center
Organization Data
Organization:
Asan Medical Center
Class:
OTHER
Study ID:
AMC 2006-130
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Asan Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Suh Cheolwon
Old Organization:
AsanMedical Center University of Ulsan College of Medicine
Collaborators
| Name | Class |
|---|---|
| Boryung Pharmaceutical Co Ltd | INDUSTRY |